• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

N-末端脑利钠肽前体与川崎病超急性期冠状动脉扩张的预测。

N-terminal pro-brain natriuretic peptide and prediction of coronary artery dilatation in hyperacute phase of Kawasaki disease.

机构信息

Department of Emergency Medicine, Seoul National University Hospital, Jongno-gu, Seoul, Republic of Korea.

Department of Emergency Medicine, Seoul Medical Center, Jungang-gu, Seoul, Republic of Korea.

出版信息

Am J Emerg Med. 2019 Mar;37(3):468-471. doi: 10.1016/j.ajem.2018.06.021. Epub 2018 Jun 8.

DOI:10.1016/j.ajem.2018.06.021
PMID:29903669
Abstract

BACKGROUND

Coronary artery dilatation (CAD) is a great concern with Kawasaki disease (KD). This study aimed to investigate the relationship between serum N-terminal pro-brain natriuretic peptide (NT-proBNP) levels and CAD in patients with the hyperacute phase (≤4 days of fever) of KD.

METHODS

Serum NT-proBNP levels were compared between patients with and those without CAD, who underwent transthoracic echocardiography (TTE) within 24 h of the hyperacute phase of KD in the pediatric emergency department (PED). Electronic medical records of patients aged 1 month to 15 years who visited the PED were retrospectively assessed from January 2010 to December 31, 2014.

RESULTS

One hundred nine patients were enrolled in the study. Twenty-three of those patients had CAD within 24 h of TTE. Median serum NT-proBNP levels were significantly higher in patients with CAD (824.1 pg/ml; interquartile range [IQR], 515.4-1570.0184.8-767.8 pg/ml) than in patients without CAD (396.4 pg/ml; IQR, 184.8-767.8 pg/ml) (p ≤ 0.001). The cutoff value of serum NT-proBNP, which predicted CAD during the hyperacute phase of KD, was 515.4 pg/ml, which yielded sensitivity of 78.26% and specificity of 61.63%. The area under the curve for NT-proBNP for predicting CAD during hyperacute KD was 0.749 (95% CI, 0.642-0.856).

CONCLUSION

Serum NT-proBNP might be an additional laboratory marker for detecting early CAD during the hyperacute phase of KD in the PED.

摘要

背景

冠状动脉扩张(CAD)是川崎病(KD)的一大关注点。本研究旨在探讨急性期(发热≤4 天)KD 患者血清 N 端脑利钠肽前体(NT-proBNP)水平与 CAD 的关系。

方法

在儿科急诊部(PED)急性期 24 小时内行经胸超声心动图(TTE)的 KD 患者中,比较 CAD 患者与非 CAD 患者的血清 NT-proBNP 水平。回顾性评估 2010 年 1 月至 2014 年 12 月 31 日期间,PED 就诊的 1 个月至 15 岁患者的电子病历。

结果

共纳入 109 例患者,其中 23 例患者在 TTE 后 24 小时内发生 CAD。CAD 患者的中位血清 NT-proBNP 水平显著高于非 CAD 患者(824.1pg/ml;四分位距[IQR]:515.4-1570.0;824.8-767.8pg/ml)(p≤0.001)。预测 KD 急性期 CAD 的血清 NT-proBNP 截断值为 515.4pg/ml,其敏感性为 78.26%,特异性为 61.63%。NT-proBNP 预测 KD 急性期 CAD 的曲线下面积为 0.749(95%CI:0.642-0.856)。

结论

血清 NT-proBNP 可能是 PED 急性期 KD 早期 CAD 的附加实验室标志物。

相似文献

1
N-terminal pro-brain natriuretic peptide and prediction of coronary artery dilatation in hyperacute phase of Kawasaki disease.N-末端脑利钠肽前体与川崎病超急性期冠状动脉扩张的预测。
Am J Emerg Med. 2019 Mar;37(3):468-471. doi: 10.1016/j.ajem.2018.06.021. Epub 2018 Jun 8.
2
N-terminal pro-brain natriuretic peptide can be an adjunctive diagnostic marker of hyper-acute phase of Kawasaki disease.N端前脑钠肽可作为川崎病超急性期的辅助诊断标志物。
Eur J Pediatr. 2016 Dec;175(12):1997-2003. doi: 10.1007/s00431-016-2798-3. Epub 2016 Oct 31.
3
[Prediction of the risk of coronary arterial lesions in Kawasaki disease by N-terminal pro-brain natriuretic peptide].N末端脑钠肽前体预测川崎病冠状动脉病变风险
Zhonghua Er Ke Za Zhi. 2015 Apr;53(4):300-3.
4
Pro-brain natriuretic peptide (ProBNP) levels in North Indian children with Kawasaki disease.北印度患有川崎病儿童的脑钠肽前体(ProBNP)水平
Rheumatol Int. 2016 Apr;36(4):551-9. doi: 10.1007/s00296-016-3430-6. Epub 2016 Feb 5.
5
Limited utilities of N-terminal pro B-type natriuretic peptide and other newer risk markers compared with traditional risk factors for prediction of significant angiographic lesions in stable coronary artery disease.与传统危险因素相比,N末端B型利钠肽原及其他新型风险标志物在预测稳定型冠状动脉疾病中显著血管造影病变方面的应用有限。
Heart. 2009 Feb;95(4):297-303. doi: 10.1136/hrt.2008.145425. Epub 2008 Aug 15.
6
Predictive potential of age-group cut-off values of N-terminal pro-brain natriuretic peptide in Kawasaki disease.N 末端脑利钠肽前体在川崎病中的年龄组截断值的预测潜力。
Pediatr Int. 2022 Jan;64(1):e15371. doi: 10.1111/ped.15371.
7
N-terminal pro-B-type natriuretic peptide diagnostic algorithm versus American Heart Association algorithm for Kawasaki disease.用于川崎病的N末端前B型利钠肽诊断算法与美国心脏协会算法的比较
Pediatr Int. 2017 Mar;59(3):265-270. doi: 10.1111/ped.13154. Epub 2016 Dec 2.
8
Cardiac function on 3-D speckle tracking imaging and cytokines in Kawasaki disease.川崎病的三维斑点追踪成像心脏功能及细胞因子
Pediatr Int. 2018 Apr;60(4):342-348. doi: 10.1111/ped.13521. Epub 2018 Mar 22.
9
N-terminal pro-brain natriuretic peptide and risk of coronary artery lesions and resistance to intravenous immunoglobulin in Kawasaki disease.N-末端脑利钠肽前体与川崎病冠状动脉病变风险及静脉注射免疫球蛋白耐药的关系。
J Pediatr. 2013 Jun;162(6):1205-9. doi: 10.1016/j.jpeds.2012.11.026. Epub 2013 Jan 3.
10
Angiopoietin-2 provides no incremental predictive value for the presence of obstructive coronary artery disease over N-terminal pro-brain natriuretic peptide.血管生成素-2 对存在阻塞性冠状动脉疾病的预测价值不能超过 N 端脑利钠肽前体。
J Clin Lab Anal. 2019 Oct;33(8):e22972. doi: 10.1002/jcla.22972. Epub 2019 Jul 1.

引用本文的文献

1
Association Between Levels of N-Terminal Pro-brain Natriuretic Peptide and Coronary Artery Lesion in Patients with Kawasaki Disease: A Systematic Review and Meta-analysis.川崎病患者N末端脑钠肽前体水平与冠状动脉病变的关联:一项系统评价和荟萃分析
Arch Rheumatol. 2025 Jun 23;40(2):256-266. doi: 10.5152/ArchRheumatol.2025.11128.
2
The relationship between N-terminal pro-brain natriuretic and coronary artery lesions in Kawasaki disease: A meta-analysis.N 端前脑钠肽与川崎病冠状动脉病变的关系:一项荟萃分析。
PLoS One. 2025 Jun 10;20(6):e0324552. doi: 10.1371/journal.pone.0324552. eCollection 2025.
3
Kawasaki disease in children younger than 6 months of age: characteristics of a Spanish cohort.
6 个月以下儿童川崎病:西班牙队列的特征。
Eur J Pediatr. 2022 Feb;181(2):589-598. doi: 10.1007/s00431-021-04215-8. Epub 2021 Aug 30.
4
Cardiac Biomarkers in Pediatrics: An Undervalued Resource.儿科心脏生物标志物:被低估的资源。
Clin Chem. 2021 Jul 6;67(7):947-958. doi: 10.1093/clinchem/hvab063.
5
Red Blood Cell Distribution Width as a Predictive Marker for Coronary Artery Lesions in Patients with Kawasaki Disease.红细胞分布宽度作为川崎病患者冠状动脉病变的预测指标
Pediatr Cardiol. 2021 Oct;42(7):1496-1503. doi: 10.1007/s00246-021-02633-x. Epub 2021 May 25.
6
N-terminal pro-brain natriuretic peptide as a biomarker for predicting coronary artery lesion of Kawasaki disease.N-末端脑利钠肽前体作为预测川崎病冠状动脉病变的生物标志物。
Sci Rep. 2020 Mar 20;10(1):5130. doi: 10.1038/s41598-020-62043-6.
7
A Decade of NT-proBNP in Acute Kawasaki Disease, from Physiological Response to Clinical Relevance.急性川崎病中NT-脑钠肽前体的十年:从生理反应到临床意义
Children (Basel). 2018 Oct 12;5(10):141. doi: 10.3390/children5100141.